Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults

被引:119
|
作者
Nakamura, M
Konishi, N
Tsunoda, S
Nakase, H
Tsuzuki, T
Aoki, H
Sakitani, H
Inui, T
Sakaki, T
机构
[1] Nara Med Univ, Dept Neurosurg, Nara 6348521, Japan
[2] Nara Med Univ, Dept Pathol 2, Nara 6348521, Japan
关键词
astrocytoma; low-grade; radiation; p53; prognosis; survival; radical surgery;
D O I
10.1159/000012087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prognostic factors for low-grade astrocytomas have been proposed, but optimal treatment remains controversial. Eighty-eight consecutive adult patients with supratentorial low-grade astrocytomas were retrospectively reviewed to determine specific factors influencing outcome. All underwent craniotomy (43 radical resections, 45 nonradical resections). Sex, age at diagnosis, preoperative Karnofsky performance status (KPS), tumor location, estimated extent of resection, radiation, chemotherapy, histological type, p53 status, MIB-1 staining and the apoptotic index were assessed as parameters for prognostic significance. KPS (p = 0.03), tumor location (p < 0.001), extent of surgical resection (p < 0.001) and radiotherapy (p = 0.01) were significantly assoicated with longer survival rates by univariate analysis. Multivariate analysis also showed a significant correlation between radiation therapy after surgical removal and survival time (p < 0.001), p53 status was not of importance in determining the necessity for radiotherapy. Radical surgical removal is the most important factor in the management of low-grade astrocytomas. Radiation therapy appears to be effective in improving the prognosis regardless of the extent of surgical resection or the p53 status. Copyright (C) 2000 S. Karger AG, Basel
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
  • [41] Early prognostic factors related to progression and malignant transformation of low-grade gliomas
    Jung, Tae-Young
    Jung, Shin
    Moon, Jung-Ho
    Kim, In-Young
    Moon, Kyung-Sub
    Jang, Woo-Youl
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (09) : 752 - 757
  • [42] Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas
    Vaquero, J
    Zurita, M
    Coca, S
    Oya, S
    Morales, C
    SURGICAL NEUROLOGY, 2000, 54 (03): : 229 - 234
  • [43] Low-grade gliomas in older patients: a retrospective analysis of prognostic factors
    Nader Pouratian
    Melike Mut
    Jay Jagannathan
    M. Beatriz Lopes
    Mark E. Shaffrey
    David Schiff
    Journal of Neuro-Oncology, 2008, 90
  • [44] Low-grade gliomas in older patients: a retrospective analysis of prognostic factors
    Pouratian, Nader
    Mut, Melike
    Jagannathan, Jay
    Lopes, M. Beatriz
    Shaffrey, Mark E.
    Schiff, David
    JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (03) : 341 - 350
  • [46] Surgical treatment of patients with low-grade astrocytomas and medically intractable seizures
    Gunnarsson, T
    Olafsson, E
    Sighvatsson, V
    Hannesson, B
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 105 (04): : 289 - 292
  • [47] PROGNOSTIC FACTORS AND SURVIVAL OF LOW-GRADE GLIOMAS IN CHILDREN AND ADOLESCENTS - A MULTICENTER STUDY IN PERU
    Diaz-Coronado, Rosdali
    Hernandez-Broncano, Eddy
    Casavilca-Zambrano, Sandro
    Campos-Sanchez, Danny
    Maza, Ivan
    Tello, Mariela
    Leon, Esmeralda
    Canari, Hernan
    Custodio, Javier
    Ojeda-Medina, Luis
    Negreiros, Tatiana
    Cordova, Olga
    Mora-Alferez, Pamela
    Garcia-Leon, Juan
    Vasquez, Liliana
    Moreira, Daniel
    Qaddoumi, Ibrahim
    NEURO-ONCOLOGY, 2022, 24 : 167 - 167
  • [48] Survival analysis of immune-related lncRNA in low-grade glioma
    Xiaozhi Li
    Yutong Meng
    BMC Cancer, 19
  • [49] Prognostic Factors and Survival Patterns in Pediatric Low-grade Gliomas Over 4 Decades
    Youland, Ryan S.
    Khwaja, Shariq S.
    Schomas, David A.
    Keating, Gesina F.
    Wetjen, Nicholas M.
    Laack, Nadia N.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (03) : 197 - 205
  • [50] Survival analysis of immune-related lncRNA in low-grade glioma
    Li, Xiaozhi
    Meng, Yutong
    BMC CANCER, 2019, 19 (01)